FAQ Directory

Here are some of the most frequently asked questions about NCQA’s various programs. If you don’t see what you are looking for in one of the entries below, you can  ask a question through My NCQA.

Filter Results
  • Save
  • Email
  • Print

7.15.2026 Portable HbA1c Device Testing for the Glycemic Status Assessment for Patients With Diabetes (GSD) measure Does NCQA approve the use of portable point-of-care HbA1c devices and are HbA1c results obtained from these devices acceptable for reporting?

HbA1c results obtained from portable point-of-care devices are acceptable when the test is performed by clinical staff, regardless of whether the test is conducted at home or in a provider office. Self-collected samples are also acceptable if sent to a laboratory or provider’s office for analysis and result calculation. Self-administered tests reported by the member do not meet criteria (General Guideline: Self-Collected Samples).

This applies to the following Programs and Years:
HEDIS MY 2026

7.15.2026 Timeliness of Requests vs. Ongoing Review What is the difference between the following two statements in UM 5 regarding timeliness?

Statement 1: Timeliness starts when the organization receives a request.

Statement 2: Timeliness starts on the day of the review for ongoing review of urgent concurrent care that was approved initially.

Both statements apply to UM decisions, but they reflect different review processes and therefore have different starting points for when assessing timeliness purposes. 

  • Statement 1 applies when the organization receives a UM request. Timeliness is measured from the date the request is received from the member or the member’s authorized representative. 
  • Statement 2 applies to subsequent reviews of previously approved urgent concurrent care when the organization has procedures for conducting ongoing reviews. In these cases, no new request is submitted. Because the organization initiates the review based on its established procedures, timeliness is measured from the date the ongoing review is conducted. 

Applicable standards: 

  • Health Plan Accreditation – UM 5, Elements A-C. 
  • Behavioral Health Accreditation – UM 5, Element A. 
  • Utilization Management Accreditation – UMA 1, Element B; UMA 2, Element B; and UMA 3, Element B.

This applies to the following Programs and Years:
HP 2026|UM 2026|BHA 2026

7.15.2026 Blood-based testing for the Colorectal Cancer Screening (COL-E) measure Does NCQA include sRNA stool or blood test as an acceptable form of screening for Colorectal Cancer Screening (COL-E) measure?

No. At this time, these tests are not included in the COL-E measure or its value sets and we cannot predict if or when sRNA type tests will be added.

NCQA relies on a broad body of scientific evidence and guidance from multiple independent clinical guideline bodies when developing and updating quality measures. These include, but are not limited to, recommendations from the U.S. Preventive Services Task Force (USPSTF), as well as other national organizations. NCQA monitors emerging screening concepts and reviews evidence as it becomes available through its established measure development processes.

Because of this, while some tests may receive FDA authorization and are covered under certain CMS policies, they are not automatically included in our measures. NCQA will continue to review the guidelines and scientific literature, and communicate changes if they are made.

This applies to the following Programs and Years:
HEDIS MY 2026

7.15.2026 Source System of Record (SSoR) Reporting and Hierarchy Guidance for ECDS Measures How should plans approach SSoR category reporting and source hierarchy/prioritization for ECDS measures in MY 2026?

Reporting by SSoR category (e.g., EMR, HIE, case management, administrative) was sunset for MY 2026 and measure results no longer need to be attributed to an SSoR category when reported.

Additionally, HEDIS MY 2026 does not include guidance on hierarchy for ECDS reported measures. The hierarchy should not change the performance result, just the data source contributing the information.

NCQA is not prescriptive about how source prioritization is programmed into the measure logic. It is up to the plan to determine how sources are prioritized when calculating results to avoid double counting and it should be done consistently across measures.

This applies to the following Programs and Years:
HEDIS MY 2026

7.15.2026 Behavioral Health Organizations for QI 2, Element C For purposes of QI 2, Element C, how does NCQA define a behavioral health organization? If a hospital offers behavioral health services, does a contract with that hospital meet the requirement?

For purposes of QI 2, Element C, behavioral health organizations include organizations that provide or manage behavioral health services, such as managed behavioral health organizations (MBHOs), inpatient psychiatric facilities and behavioral health clinics.  

A hospital contract alone is not sufficient to meet the intent of the requirement because a hospital relationship may only provide limited, episodic data and may not reflect comprehensive data integration across the behavioral health continuum. 

However, if the organization can demonstrate that the contracted entity provides behavioral health services beyond limited or episodic inpatient care and that the behavioral health data support assessment of care and outcomes for the behavioral health population, it may be considered a behavioral health organization for QI 2, Element C. 

Applicable standards: 

  • Health Plan Accreditation – QI 2, Element C. 

This applies to the following Programs and Years:
HP 2026

7.02.2026 Multi-Site Sampling for Large Organizations (CM 04)

NCQA is introducing a new optional tier-based multi-site sampling approach for Person-Centered Care Plans to reduce Annual Reporting burden for larger organizations.

Organizations requesting multi-site sampling should submit requests through My.NCQA at least six months prior to the reporting date. For the initial rollout, NCQA will allow some flexibility and encourages organizations to submit requests as soon as possible prior to their reporting date. Beginning January 1, 2027, all requests should be submitted at least six months in advance of the reporting date. NCQA will review submitted requests and provide the sampled subset of sites back to the organization.

Organizations that would like to align the reporting dates of some, or all, of their sites should submit the request along with their multi-site sampling request, through My.NCQA. 

 Who is eligible:

  • Organizations with 9 or more sites.
  • Sites must share the same reporting date.

What this means:

  • Eligible organizations may submit care plans from a subset of sites selected by NCQA
  • Sampling is based on organization size.
  • Upload 3 de-identified care plans for managed care patients per sampled site.
  • Submitted care plans must represent 3 of the 5 care plan categories listed in CM 01: Identifying Patients for Care Management.

Note: This option applies to written care plans only. Practices must still report the number of patients who have a care plan per site.

If you are interested in using this option or would like to confirm eligibility, please contact your NCQA Representative via My.NCQA.
 

This applies to the following Programs and Years:
PCMH 2017

7.01.2026 What changes were made to the PCSP Standards and Guidelines for Version 9?

KM 06   KM 06 is now titled Demographic Data Collection. 
CC 13: External Electronic Exchange of Information   Added D. Clinical data exchange with payers (1 Credit). CC 13 is now worth up to 4 points. 

This applies to the following Programs and Years:
PCSP 2019

7.01.2026 What changes were made to the PCMH Standards and Guidelines for Version 12?

KM 09   KM 09 is now titled Demographic Data Collection. 
KM 20: Clinical Decision Support   Added a clarification that screenings to not meet the intent of KM 20. 
AC 11: Patient Visits with Clinician/Team   Added a clarification that single-clinician sites automatically meet this criterion. 
CM 01: Identifying Patients for Care Management    Added pediatric-specific practice sites must include at least two categories instead of three. 
CM 01: Identifying Patients for Care Management    Changed from shared evidence to site-specific evidence. 
CM 02: Monitoring Patients for Care Management   Added, "At minimum, a practice must identify at least 30 patients for care management, or 1% of its total patient   population, whichever is smaller, to meet the criteria defined in CM 01." 
CM 04: Person-Centered Care Plans   Updated that care plans must include: 

  • Active problem list  
  • Expected clinical outcome/prognosis and patient treatment goal OR a SMART goal. 
  • Medication list and management. 
  • A schedule to review and revise the plan, as needed. 
CM 04: Person-Centered Care Plans   Added, "If your organization has 9 or more sites, please reach out to your PCMH Representative, via PCS,   regarding adjusting the sample size." 
MAC Policy (Appendix 6)   Added a new section for practices who change EHRs due to a MAC. 
Distinction BH 03: BH Clinician in the Practice   Added the clarification, "Simple co-location does not meet the requirement." 
PCMH AR    Clarified in Front Matter that the documented process must contain the date of implementation. 

 Clarified in Front Matter that a report upload submission must include the reporting period, numerator and   denominator descriptions, numerator and denominator data and the percentage. 

This applies to the following Programs and Years:
PCMH 2017

6.15.2026 BR, NR and NQ Audit Designations for QI 3, Element B In the Related Information section of QI 3, Element B, the table under "Handling missing values" indicates that all the audit designations should not be included in the 3.0 average calculation. However, Example 2 includes a missing value (such as "BR" audit designation) in the calculation. Should BR, NR and NQ follow Example 2 and be included in the calculation of the 3.0 average?

Yes. The "Handling Missing Values" table in the Related Information section is incorrect for the BR, NR and NQ audit designations. If any measure has a BR (Biased Rate), NR (Not Reported) or NQ* (Not Required) audit designation, it is assigned a rating of 0 and included in the calculation of the 3.0 average.

The information above is a correction to the Policy Update issued in March 2026 for QI 3, Element B.

*Accredited health plans may not use the NQ audit designation for measures included in the Health Plan Ratings measure list.

Applicable standards: 
•    Health Plan Accreditation: QI 3, Element B

This applies to the following Programs and Years:
HP 2026

6.15.2026 SMI and SED for PHM 2, Element B, Factor 4 Do organizations need to assess members with SMI, SED, or both?

For PHM 2, Element B, factor 4 the organization must assess the needs of members with serious mental illness (SMI) and assess the needs of members with serious emotional disturbance (SED). If a member has both conditions, separate assessments are not required under factor 4. The organization determines if the member is assessed as a member with SMI or SED.

Applicable standards: 
•    Health Plan Accreditation – PHM 2, Element B
•    Behavioral Health Accreditation – PHM 2, Element B

This applies to the following Programs and Years:
HP 2026|BHA 2026

6.15.2026 Ongoing Monitoring of Licensure and Sanctions NCQA released a March 2026 Policy Update requiring organizations to monitor sanctions and licensure limitations in all states where a practitioner practices, even if those states are outside the organization’s service area or are not states where the practitioner provides care to the organization’s members. Can NCQA clarify the scope and effective date of this change?

For the 2026 standards year only, NCQA is limiting the expanded monitoring requirement under CR 5, Element A, factor 3 to practitioners initially credentialed on or after July 1, 2026. Organizations are not required to apply this expanded monitoring requirement to practitioners credentialed before this date. 

For the 2027 standards year and beyond, the expanded requirement applies to all practitioners for surveys on or after July 1, 2027.

Applicable Standards:

  • HPA: CR 5, Element A, factor 3
  • BHA: CR 5, Element A, factor 3
  • CRPN: CRA 5, Element A, factor 3 and CRC 12, Element B, factor 3

This applies to the following Programs and Years:
HP 2026|BHA 2026|CRPN 2026

6.15.2026 Communication to Practitioners About Availability of UM Criteria The scope of review under UM 4, Element B: Availability of UM Criteria in UM Accreditation and Behavioral Health Accreditation (BHA) states that NCQA reviews the organization’s electronic communication of criteria availability to each practitioner. This same language does not appear in the corresponding requirement in Health Plan Accreditation (HPA). Will NCQA review electronic communication to practitioners regarding the availability of UM criteria under UM 4, Element B in UM Accreditation and BHA?

No. To align with HPA, NCQA does not review communication to practitioners about the availability of UM criteria in UM 4, Element B in UM Accreditation or BHA. Instead, NCQA evaluates whether the organization makes the criteria available electronically (e.g., through an EHR, portal, or website). Acceptable evidence includes system reports or screenshots demonstrating how practitioners access the criteria at the point of care.

Applicable standards:

  • Utilization Management Accreditation – UM 4, Element B
  • Behavioral Health Accreditation – UM 2, Element B

This applies to the following Programs and Years:
HP 2026|UM 2026|BHA 2026